A risk-benefit assessment of therapies for premature labour

Drug Safety

Volumn 21, Issue 1, 1999, Pages 35-56

  Higby, Kenneth ^a,c   Suiter, Cheryl R ^b  

^a San Antonio Uniformed Services Health Education Consortium   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c 59th MDW/MNO ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM ANTAGONIST; INDOMETACIN; MAGNESIUM SULFATE; NIFEDIPINE; OXYTOCIN ANTAGONIST; PROSTAGLANDIN INHIBITOR; SULINDAC;

ALLERGIC REACTION; BLEEDING; DIARRHEA; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; GESTATIONAL AGE; HEADACHE; HEART PALPITATION; HEARTBURN; HOT FLUSH; HUMAN; HYPOCALCEMIA; ILEUS; LETHARGY; LIVER TOXICITY; MUSCLE WEAKNESS; NAUSEA; NEWBORN MORBIDITY; NEWBORN MORTALITY; PEPTIC ULCER; PREMATURE LABOR; PRIORITY JOURNAL; RASH; RESTLESSNESS; REVIEW; RISK BENEFIT ANALYSIS; THORAX PAIN; THROMBOCYTOPENIA; TREMOR; URINE RETENTION; UTERUS CONTRACTILITY; VISUAL DISORDER; VOMITING;

ANIMALS; FEMALE; HUMANS; OBSTETRIC LABOR, PREMATURE; PREGNANCY; RISK ASSESSMENT;

EID: 0032820225     PISSN: 01145916     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002018-199921010-00004     Document Type: Review

References (242)

1. 1. Wynn M, Wynn A. The prevention of preterm birth. London: Foundation for Education and Research in Child-Bearing, 1997
2. 2. ODriscoll M, Discussion, In: Anderson A, Beard R, Brudenell JM, et al., editors. Preterm labour. Proceedings of the Fifth Study Group of the Royal College of Obstetricians and Gynaecologists. London: Royal College of Obstetricians and Gynaecologists, 1977; 369-70
3. 3. Caritis SN, Edelstone DI, Mueller-Heubach E. Pharmacologic inhibition of preterm labour. Am J Obstet Gynecol 1979; 133: 557-78
4. 4. Castrén O, Gummerus M, Saarikoski S. Treatment of imminent premature labour: a comparison between the effects of nylidrin chloride and isoxsuprine chloride as well as of ethanol. Acta Obstet Gynecol Scand 1975; 54: 95-100
5. 5. Chekhov AP. The cherry orchard [translated by Avrahm Yarmolinsky]. New York: Avon Books, 1968
6. 6. Bishop EH, Woutersz TB. Isoxsuprine, a myometrial relaxant: a preliminary report. Obstet Gynecol 1961; 17: 442-6
7. 7. Hendricks CH, Cibils LA, Pose SV, et al. The pharmacologic control of excessive uterine activity with isoxsuprine. Am J Obstet Gynecol 1961; 82: 1064-78
8. 8. Das R. Isoxsuprine in premature labour. J Obstet Gynaecol India 1969; 19: 566-70
9. 9. Sivasamboo R. Premature labour. In: Baumgarten K, WesseliusDe Casparis A, editors. Proceedings of the international symposium on the treatment of fetal risks; 1972 May; Baden, Austria. Vienna: University of Vienna Medical School, 1972: 16-20
10. 10. Csapo AI, Herczeg J. Arrest of premature labour by isoxsuprine. Am J Obstet Gynecol 1977; 129: 482-91
11. 11. Lauersen NH, Merkatz IR, Tejani N, et al. Inhibition of premature labour: a multicenter comparison of ritodrine and ethanol. Am J Obstet Gynecol 1977; 127: 837-45
12. 12. Christensen KK, Ingemarsson I, Leideman T, et al. Effect of ritodrine on labour after premature rupture of the membranes. Obstet Gynecol 1980; 55: 187-90
13. 11. Merkatz IR, Peter JB, Barden TP. Ritodrine hydrochloride: a betamimetic agent for use in preterm labour. II. Evidence of efficacy. Obstet Gynecol 1980; 56: 7-12
14. 14. Penney LI., Daniell WC. Estimation of success in treatment of premature labour: applicability of prolongation index in a double-blind, controlled, randomized trial. Am J Obstet Gynecol 1980; 138: 345-6
15. 15. Calder AA, Patel NB. Are betamimetics worthwhile in preterm labour? In: Beard RW, Sharp F, editors. Pre-term labour and its consequences. Proceedings of the Thirteenth Study Group of the Royal College of Obstetricians and Gynaecologists. London; Royal College of Obstetricians and Gynaecologists, 1985: 209-18
16. 16. Weiner CP, Renk K, Klugman M. The therapeutic efficacy and cost-effectiveness of aggressive tocolysis for premature labour associated with premature rupture of the membranes. Am J Obstet Gynecol 1988; 159: 216-22
17. 17. Keirse M. Grant A, King J. Preterm labour. In; Chalmers I, Enkin M, Keirse M, editors, Effective care in pregnancy and childbirth. Oxford: Oxford University Press, 1989: 701
18. 18. Spellacy WN, Cruz AC, Birk SA, et al. Treatment of premature labour with ritodrine: a randomized controlled study, Obstet Gynecol 1979; 54: 220-3
19. 19. Adam GS. Isoxsuprine and premature labour. Aust NZ J Obstet Gynaecol 1966; 6: 294-8
20. 20. Larsen JF, Kern Hansen M, Hesseldahl H, et al. Ritodrine in the treatment of preterm labour: a clinical trial to compare a standard treatment wild three regimens involving the use of ritodrine. Br J Obstet Gynaecol 1980; 87: 949-57
21. 21. Howard Jr TE, Killam AP, Penney LL, et al. A double blind randomized study of terbutaline in premature labour. Mil Med 1982; 147: 305-7
22. 22. Cotton DB, Strassner HT, Hill LM, et al. Comparison of magnesium sulfate, terbutaline and a placebo for inhibition of preterm labour: a randomized study, J Reprod Med 1984; 29: 92-7
23. 23. Leveno KJ, Guzick DS, Hankins GDV et al. Single-centre randomised trial of ritodrine hydrochloride for preterm labour. Lancet 1986; 1: 1293-6
24. 24. Canadian Preterm Labour Investigators Group, The treatment of preterm labour with beta-adrenergic agonist ritodrine. N Engl J Med 1992; 327: 308-12
25. 25. Wesselius-De Casparis A, Thiery M, Yo Le Sian A, et al. Results of double blind, multicentre study with ritodrine in premature labour. BMJ 1971; 3: 144-7
26. 26. Ingemarsson I. Effect of terbutaline on premature labour. Adouble-blind placebo-controlled study. Am J Obstet Gynecol 1976; 125: 520-4
27. 27. Larsen JF, Eldon K, Lange AP, et al, Ritodrine in the treatment of preterm labour: second Danish multicenter study. Obstet Gynecol 1986; 67: 607-13
28. 28. Guinn DA, Goepfert AR, Owen J, et al. Terbutaline pump for prevention of preterm delivery; a double blind, placebo-controlled trial [abstract no. 42], Am J Obstet Gynecol 1998; 178: S19
29. 29. Wenstrom K, Weiner C, Merrill D, et al. A placebo-controlled randomized trial of the terbutaline pump for prevention of preterm delivery. Am J Perinatol 1997; 14: 87-91
30. 30. Wagner JM, Morton MJ, Johnson KA, et al. Terbutaline and maternal cardiac function. JAMA 1981; 246: 2697-701
31. 31. Bieniarz J, Ivankovich A, Scommegna A. Cardiac output during ritodrine treatment of premature labour. Am J Obstet Gynecol 1974; 118: 910-9
32. 32. Katz M, Robertson PA, Creasy RK, Cardiovascular complications associated with terbutaline treatment for preterm labour. Am J Obstet Gynecol 1981; 139: 605-8
33. 33. Kjer JJ, Pedersen KH, Persistent supraventricular tachycardia following infusion with ritodrine hydrochloride. Acta Obstet Gynecol Scand 1982; 61: 281-2
34. 34. Fink BJ, Webert T. Direct current conversion of maternal supra-ventricular tachycardia developed during the treatment of a pregnant heroin addict with ritodrine. Acta Obstet Gynecol Scand 1981; 60: 521-2
35. 35. Carpenter Jr RJ, Decuir P. Cardiovascular collapse associated with oral terbutaline tocolytic therapy. Am J Obstet Gynecol 1984; 148: 821-3
36. 36. Frederiksen MC, Toig RM, Depp III R. A trial fibrillation during hexoprenaline therapy for premature labour. Am J Obstet Gynecol 1983; 145: 108-9
37. 37. Schneider EP, Jonas E. Tejani N. Detection of cardiac events by continuous electrocardiographic monitoring during ritodrine infusion, Obstet Gynecol 1988; 71: 361-4
38. 38. Chen WC, Lew LC. Ventricular ectopics after salbutamol infusion for preterm labour. Lancet 1979; 2: 1383-4
39. 39. Hendricks SK, Keroes J, Katz M. Electrocardiographic changes associated with ritodrine-induced maternal tachycardia and hypokalemia. Am J Obstet Gynecol 1986; 154: 921-3
40. 40. Cohen GR, OBrien WF, Knuppel RA. ST segment depression in paired electrocardiograms and serum electrolytes in pregnant women receiving intravenous ritodrine. J Reprod Med 1988; 33: 768-70
41. 41. Perry KG, Morrison JC, Rust OA, et al. Incidence of adverse cardiopulmonary effects with low-dose continuous terbutaline infusion. Am J Obstet Gynecol 1995; 173: 1273-7
42. 42. Hudgens DR, Conradi SE. Sudden death associated with terbutaline sulfate administration. Am J Obstet Gynecol 1993; 169: 120-1
43. 41. Kubli F. Discussion. In; Anderson A, Beard R, Brudenell JM, et al, editors. Proceedings of the Fifth Study Group of the Royal College of Obstetricians and Gynaecologists. London: Royal College of Obstetricians and Gynaecologists, 1977: 218-20
44. 44. Elliot HR, Abdulla U. Pulmonary oedema associated with ritodrine infusion and betamethasone administration in premature labour. BMJ 1978; 2: 799-800
45. 45. MacLennan FM, Thomson MA, Rankin R, et al. Fatal pulmonary oedema associated with the use of ritodrine in pregnancy. Case report. Br J Obstet Gynaecol 1985; 92: 703-5
46. 46. Nimrod CA, Beresford P, Frais M, et al. Hemodynamic observations on pulmonary edema associated with a betamimetic agent: a report of two cases. J Reprod Med 1984; 29: 141-4
47. 47. Nimrod C, Rambihar V, Fallen E, et al. Pulmonary edema associated with isoxsupine therapy, Am J Obstet Gynecol 1984; 148: 625-9
48. 48. Evron S, Samueloff A, Mor-Yosef S, et al. Pulmonary edema occurring after isoxsuprine and dexamethasone treatment for preterm labour: case report. J Perinat Med 1983; 11: 272-7
49. 49. Mabic WC, Pernoll ML, Witty JB, et al. Pulmonary edema induced by betamimetic drugs. South Med J 1983; 76: 1.154-60
50. 50. Grospietsch G, Fenske M, Girndt J, et al. The renin-angiotensin-aldosterone system, antidiuretic hormone levels and water balance under locolytic therapy with fenoterol and verapamil. Int J Gynaecol Obstet 1980; 17: 590-5
51. 51. Hanssens M, Keirse MJ, Symonds EM. Activation of the reninangiotensin system during ritodrine treatment in preterm labour. Am J Obstet Gynaecol 1990; 162: 1048-53
52. 52. Lammintausta R, Erkkola R. Effect of long-term salbutamol treatment of renin aldosterone system in twin pregnancy. Acta Obstet Gynecol Scand 1979; 58: 447-51
53. 53. Gross TL, Sokol RJ. Severe hypokalemia and acidosis: a potential complication of beta-adrenergic treatment. Am J Obstet Gynecol 1980; 138: 1225-6
54. 54. Grospietscb G, Kuhn W. Effects of β-mimetics on maternal physiology. In: Fuchs F, Stubblefield PG, editors. Preterm birth: causes, prevention and management. New York: Macmillan. 1984: 171-96
55. 55. Schreyrer P, Caspi E, Ariely S, et al. Metabolic effects of intravenous ritodrine infusion during pregnancy. Eur J Obstet Gynecol Reprod Biol 1979; 9: 97-103
56. 56. Spellacy WN, Cruz AC, Buhi WC, et al. The acute effects of ritodrine infusion on maternal metabolism: measurements of levels of glucose, insulin, glucagon, triglycerides, cholesterol, placental lactogen, and chorionic gonadotropin. Am J Obstet Gynecol 1978; 131: 637-42
57. 57. Caldwell G, Scougall I, Boddy K, et al. Fasting hyperinsulinemic hypoglycemia after ritodrine therapy for premature labour. Obstet Gynecol 1987; 70: 478-80
58. 58. Lipshitz J, Vinik A. The effects of hexoprenaline, a beta2-sympathomimetic drug, on maternal glucose, insulin, glucagon, and free fatty acid levels. Am J Obstet Gynecol 1978; 130: 761-4
59. 59. Berkus M, Higby K, McCoy C, et al, Pathophysiology of terbutaline induced glucose intolerance [abstract no. 257]. Am J Obstet Gynecol 1995; 172
60. 60. Smigaj D, Roman-Drago NM, Amini SB, et al. The effect of oral terbutaline on maternal glucose metabolism and energy expenditure in pregnancy. Am J Obstet Gynecol 1998; 178: 1041-7
61. 61. Suzuki M, Inagaki K, Kihira M, et al. Maternal liver impairment associated with prolonged high-dose administration of terbulaline for premature labour. Obstet Gynecol 1985; 66: 145-55
62. 62. Lotgering FK, Lind J, Huikeshoven FJM, et al. Elevated serum transaminase levels during ritodrine administration. Am J Obstet Gynecol 1986; 155: 390-2
63. 63. Nair GV, Ghosh AK, Lewis BV. Bowel distension during treatment of premature labour with beta-receptor agonists [letter]. Lancet 1976; I (7965): 907
64. 64. Sholl JS, Hughey MJ, Hirschmann RA. Myotonic muscular dystrophy associated with ritodrine tocolysis. Am J Obstet Gynecol 1985; 151: 83-6
65. 65. Parer S, Jullien Y, Rochette A, et al. Postpartum cardiomyopathy attributed to the use of beta-mimetics. Ann Fr Anesth Reanim 1983; 2: 86-8
66. 66. Catanzarite VA, Mellargue AM, Sandberg EC, et al. Respiratory arrest during therapy for premature labour in a patient with myasthenia gravis. Obstet Gynecol 1984; 64: 819-22
67. 67. Bosnyak S, Baron JM, Schreiber J. Acute cutaneous vasculitis associated with prolonged intravenous ritodrine hydrochloride therapy. Am J Obstet Gynecol 1991; 165: 427-8
68. 68. Horowitz JJ, Creasy RK. Allergic dermatitis associated with administration of isoxsuprine during premature labour. Am J Obstet Gynecol 1978; 131: 225-6
69. 69. Gonen R, Sambert I, Sharf M. Hypertensive crisis associated with ritodrine infusion and betamethasone administration in premature labour, Eur J Obstet Gynecol Reprod Biol 1982; 13; 129-32
70. 70. White-head Ml, Mander AM, Hertogs K, et al. Acute congestive cardiac failure in a hypertensive woman receiving salbutamol for premature labour. BMJ 1980; 280: 1221-2
71. 71. Bass O, Friedemann M, Junzli H. A case of acute left myocardial insufficiency after tocolysis by means of beta stimulation. Schweiz Med Wochenschr 1979; 109: 1427-30
72. 72. Anonymous. Cardiac failure in a hypertensive woman receiving salbutamol for premature labour [letter], BMJ 1980; 281: 226-7
73. 73. Muro M, Shono H, Oga M, et al, Ritodríne-induced agranulocytosis. Int J Gynaecol Obstet 1991; 36: 329-31
74. 74. Ngwingtin L, Stroch-Marcy A, Hardy F, et al. Acute cerebral ischemia: an uncommon complication of ritodrine [in French]? J Gynecol Obstet Biol Reprod (Paris) 1987; 16 (7): 915-7
75. 75. Sherer DM, Nawrocki MN, Thompson HO, et al, Type I second-degree AV block (Mobitz type I. Wenekebach AV block) during ritodrine therapy for preterm labour. Am J Perinatol 1991; 8: 150-2
76. 76. Brittain C, Carlson JW, Gehlbach DL, et al. A case report of massive vulvar edema during tocolysis of preterm labour. Am J Obstet Gynecol 1991; 165: 420-2
77. 77. Russi EW, Spaetling L, Gmur J, et al. High permeability pulmonary edema (ARDS) during tocolytic therapy: a case report. J Perinat Med 1988; 16: 45-9
78. 78. DiOrio Jr J, Brauner RE. Adult respiratory distress syndrome occurring after therapy with diazoxide and betamethasone for premature labour: a case report. RI Med J 1982; 65: 275-7
79. 79. Alcena V. Severe hemolytic anemia, leukemoid reaction, acidosis, hypokalemia, and transient hepatitis associated with the administration of ritodrine hydrochloride (Yutopar). Am J Obstet Gynecol 1982; 144: 852-4
80. 80. Hankins GDV. Complications of beta-sympathomimetic tocolylic agents. In: Clark SL, Cotton DB, Hankins GDV, et al., editors. Critical care obstetrics. 2nd ed. Boston: Blackwell Scientific, 1991: 231-44
81. 81. Ingemarsson I, Westgren M, Lindberg C, et al. Single injection of terbutaline in term labour: placental transfer and effects on maternal and fetal carbohydrate metabolism. Am J Obstet Gynecol 1981; 139: 697-701
82. 82. Westgren M, Carlsson C, Lindholm T, et al. Continuous maternal glucose measurements and fetal glucose and insulin levels after administration of terbutaline in term labour. Acta Obstet Gynecol Scand Suppl 1982; 108: 63-5
83. 83. Meissner J, Klostermann H. Distribution and diaplacental passage of infused 'H-tenoterol hydrobromide (Partusisten) in the gravid rabbit. Int J Clin Pharmacol Biopharm 1976; 13: 27-35
84. 84. Brazy JE, Little V, Grimm J, et al. Risk:benefit considerations for the use of isoxsuprine in the treatment of premature labour. Obstet Gynecol 1981; 58: 297-303
85. 85. Gandar R, deZoeten LW, Van der School JB. Serum level of ritodrine in man. Eur J Clin Pharmacol 1980; 17: 117-22
86. 86. Van Lierde M, Thomas K, Ritodrine concentrations in maternal and fetal serum and amniotic fluid. J Perinat Med 1982; 10: 119-24
87. 87. Gross TL, Kuhnert BR, Kuhner PM, et al. Maternal and fetal plasma concentrations of ritodrine. Obstet Gynecol 1985; 65: 793-7
88. 88. Borrisud M, OShaughnessy R, Alexander MS, et al. Metabolism and disposition of ritodrine in a pregnant baboon. Am J Obstet Gynecol 1985; 152: 1067-72
89. 89. Fujimoto S, Akahane N, Sakai A. Concentrations of ritodrine hydrochloride in maternal and fetal serum and amniotic fluid following intravenous administration in late pregnancy. Eur J Obstet Gynecol Reprod Biol 1986; 23: 145-52
90. 90. Bergman B, Bokstrom H, Borga O, et al. Transfer of terbutaline across the human placenta in late pregnancy. Eur J Respir Dis Suppl 1984; 134: 81-6
91. 91. Hancock PJ, Setzer ES, Beydoun SN, Physiologic and biochemical effects of ritodrine therapy on the mother and perinate. Am J Perinatol 1985; 2: 1-6
92. 92. Unbehaun V, Effects of sympathomimetic tocolylic agents on the fetus, J Perinat Med 1974; 2: 17-29
93. 93. Krapohl AJ, Anderson JM, Evans TN. Isoxsuprine suppression of uterine activity. Obstet Gynecol 1968; 32: 178-87
94. 94. Caritis SN, Morishima O, Stark RI, et al. Effects of terbutaline on the pregnant baboon and fetus. Obstet Gynecol 1977; 50: 56-60
95. 95. Dawson AM, Davies JH. The effect of intravenous and oral salbutamol on fetus and mother in premature labour. Br J Obstet Gynaecol 1977; 84: 348-53
96. 96. Brown SM, Tejani NA. Terbutaline sulfate in the prevention of recurrence of premature labour. Obstet Gynecol 1981; 57: 22-5
97. 97. Rayburn W, Piehl E, Schork A, et al. Intravenous ritodrine therapy: a comparison between twin and singleton gestations. Obstet Gynecol 1986; 67: 243-8
98. 98. Sharif DS, Huhta JC, Moise Jr KJ, et al. Changes in fetal hemodynamics with terbutaline treatment and premature labour. J Clin Ultrasound 1990; 18: 85-9
99. 99. Crawford C, Bowen Jr F, Bhutani V, et al. Echocardiographic effects of intrauterine isoxsuprine exposure. Pediatr Res 1981; 15: 493
100. 100. Hermansen SC, Johnson GL, Neonatal supraventricular tachycardia following prolonged maternal ritodrine administration. Am J Obstet Gynecol 1984; 149: 778-9
101. 101. Gemelli M, De Luca F, Manganaro R, et al. Transient electrocardiographic changes suggesting myocardial ischaemia in newborn infants following tocolysis with beta-sympathomi metics. Eur J Pediatr 1990; 149: 730-3
102. 102. Fletcher SE, Fyfe DA, Case CL, et al. Myocardial necrosis in a newborn after long-term maternal subcutaneous terbutaline infusion for suppression of preterm labour. Am J Obstet Gynecol 1991; 165: 1401-4
103. 103. Lenke RR, Trupin S. Sudden, unforeseen fetal death in a woman being treated for premature labour: a case report. J Reprod Med 1984; 29: 872-4
104. 104. Katz VL, Seeds JW. Fetal and neonatal cardiovascular complications from β-sympathomimetic therapy for tocolysis. Am J Obstet Gynecol 1989; 161: 1-4
105. 105. Wiedinger H, Mohr D, Haller K, et al. Zeitlicher Verlauf der Blutglukose, des immuno-reaktiven Insulins und der Kaliumionen heim Neugeborenen nach langzeitigen und akuten Gabe von Partusisten mit und ohne Isoptin. Z Geburtshilfe Perinatol 1976; 180: 258-65
106. 106. Epstein MF, Nicholls E, Stubblefield PG. Neonatal hypoglycemia after beta sympathomimetic tocolytic therapy. J Pediatr 1979; 94: 449-53
107. 107. Van de Walle AF, Martin Jr CB. The effect of a low dose infusion of ritodrine on cardiac output distribution and uteroplacental blood flow in unanesthetized pregnant guinea pigs. Eur J Obstet Gynecol Reprod Biol 1987; 25: 67-75
108. 108. Ehrenkranz RA, Walker AM, Oakes GK, et al. Effect of ritodrine infusion on uterine and umbilical blood flow in pregnant sheep. Am J Obstet Gynecol 1976; 126: 343-9
109. 109. Ehrenkranz RA, Hamilton Jr LA, Brennan SC, et al. Effects of salbutamol and isoxsuprine on uterine and umbilical blood flow in pregnant sheep. Am J Obstet Gynecol 1977; 128; 287-93
110. 110. Brennan SC, Mclaughlin MK, Chez RA. Effects of prolonged infusion of beta-adrenergic agonists on uterine and umbilical blood flow in pregnant sheep. Am J Obstet Gynecol 1977; 128: 709-15
111. 111. Van de Walle AF, Martin Jr CB. Effect of ritodrine on uteroplacental blood flow and cardiac output distribution in unanesthetized pregnant guinea pigs. Am J Obstet Gynecol 1986; 154: 189-94
112. 112. Lunell NO, Joelsson I, Lewander R, et al. Utero-placental blood flow and the effect of beta 2-adrenoceptor stimulating drugs. Acta Obstet Gynecol Scand Suppl 1982; 108: 25-8
113. 113. Van de Walle AF, Martin Jr CB. Effect of prolonged infusion of ritodrine on uteroplacental blood flow and cardiac output distribution in unanesthetized pregnant guinea pigs. Eur J Obstet Gynecol Reprod Biol 1986; 21: 253-60
114. 114. Lippert TH, DeGrandi PB, Fridrich R. Actions of the uterine relaxant, fenoterol, on uteroplacental hemodynamics in human subjects. Am J Obstet Gynecol 1976; 125: 1093-8
115. 115. Brettes JP, Renaud R, Gandar R. A double-blind investigation into the effects of ritodrine on uterine blood flow during the third trimester of pregnancy. Am J Obstet Gynecol 1976; 124: 164-8
116. 116. Ehrenkranz RA, Walker AM, Oakes GK, et al. Effect of fenoterol (Th 1165a) infusion on uterine and umbilical blood flow in pregnant sheep. Am J Obstet Gynecol 1977; 128: 177-82
117. 117. Curitis SN, Mueller-Heubach E, Morishima HO, et al. Effect of terbutaline on cardiovascular state and uterine blood flow in pregnant ewes. Obstet Gynecol 1977; 50: 603-6
118. 118. Jouppila P, Kirkinen P, Koivula A, et al. Ritodrine infusion during late pregnancy: effects on fetal and placental blood flow, prostacyclin, and thromboxane. Am J Obstet Gynecol 1985; 151: 1028-32
119. 119. Brazy JE, Eckerman CO, Gross SJ. Follow-up of infants of less than 1500 grams birth weight with antenatal isoxsuprine exposure. J Pediatr 1983; 102: 611-3
120. 120. Hadders-Algra M, Touwen BC, Huisjes HJ. Longterm follow-up of children prenatally exposed to ritodrine. Br J Obstet Gynecol 1986; 1: 156-61
121. 121. Polowezyk D, Tejani N, Lauersen N, et al. Evaluation of seven-to-nine year-old children exposed to ritodrine in utero. Obstet Gynecol 1984; 64: 485-8
122. 122. Svenningsen NW. Follow-up studies on preterm infants after maternal beta-receptor agonist treatment. Acta Obstet Gynecol Scand Suppl 1982; 108: 67-70
123. 123. Karlsson K, Krantz M, Hamberger L. Comparison of various betamimetics on preterm labour, survival and development of the child. J Perinat Med 1980; 8: 19-26
124. 124. Freysz H, Willard D, Lehr A, et al. A long term evaluation of infants who received a beta-mimetic drug while in utero. J Perinat Med 1977; 5: 94-9
125. 125. Groome LJ, Goldenberg RL, Cliver SP, et al. Neonatal periventricular-intraventricular hemorrhage after maternal β-sympathomimetic tocolysis. Am J Obstet Gynecol 1992; 167: 873-9
126. 126. Pranikoff J, Helmchen R, Evertson L. Tocolytic therapy and intraventricular hemorrhage in the neonate [abstract no. 510]. Am J Obstet Gynecol 1991; 164: 387
127. 127. Kupfermine M, Lessing JB, Yaron Y, et al. Nifedipine versus ritodrine for suppression of preterm labour. Br J Obstet Gynaecol 1993; 100: 1090-4
128. 128. Monga M, Creasy RK. Pharmacologic management of preterm labour. Semin Perinatol 1995; 19: 84-96
129. 129. McCombs J. Update on tocolytic therapy. Ann Pharmacother 1995; 29: 515-22
130. 130. Meyer WR, Randall HW, Graves WL. Nifedipine versus ritodrine for suppressing preterm labour. J Reprod Med 1990; 35: 649-53
131. _ 131. Ferguson JE, Dyson DC, Schutz T, et al. A comparison of tocolysis with nifedipine or ritodrine: analysis of efficacy and maternal, fetal and neonatal outcome. Am J Obstet Gynecol 1990; 163: 105-11
132. 132. Ferguson JE, Dyson DC, Holbrook Jr RH, et al. Cardiovascular and metabolic effects associated with nifedipine and ritodrine tocolysis. Am J Obstet Gynecol 1989; 161: 788-95
133. 133. Bracero LA, Leikin E, Kirshenbaum N, et al. Comparison of nifedipine and ritodrine for the treatment of preterm labour. Am J Perinatol 1991; 8 (6): 365-9
134. 134. van Dijk KG, Dekker GA, Geijn HP. Ritodrine and nifedipine as tocolytic agents: a preliminary comparison. J Perinat Med 1995; 23 (5): 409-15
135. 135. Read D, Wellby DE. The use of a calcium antagonist (nifedipine) to suppress preterm labour. Br J Obstet Gynaecol 1986; 93: 933-7
136. 136. Koks CAM, Brolmann HAM, de Kleme MJK, et al. A randomized comparison of nifedipine and ritodrine for suppression of preterm labour. Eur J Obstet Gynecol Reprod Biol 1998; 77: 171-6
137. 137. Ulmsten U. Treatment of normotensive and hypertensive patients with preterm labour using oral nifedipine, a calcium antagonist. Arch Gynecol 1984; 236: 69-73
138. 138. Snyder SW, Cardwll MS. Neuromuscular blockade with magnesium sulfate and nifedipine. Am J Obstet Gynecol 1989; 161: 35-6
139. 139. Mari G, Kirshon B, Moise KJ, et al. Doppler assessment of the fetal and uteroplacental circulation during nifedipine therapy for preterm labour. Am J Obstet Gynecol 1989; 161: 1514-8
140. 140. Fuchs AR, Fuchs F, Husslein P, et al. Oxytocin receptors in the human uterus during pregnancy and parturition. Am J Obstet Gynecol 1984; 150: 734-41
141. 141. Fuchs AR, Fuchs F, Husslein P, et al. Oxytocin receptors and human parturition: a dual role for oxytocin in the initiation of labour. Science 1982; 215: 1396-8
142. 142. Bossman T, Akerlund M, Fantoni G, et al. Receptors for and myometrial responses to oxytocin and vasopressin in preterm and term human pregnancy: effects of the oxytocin antagonist atosiban. Am J Obstet Gynecol 1994; 171: 1634-42
143. 143. Keirse MJ. New perspectives for the effective treatment of preterm labour. Am J Obstet Gynecol 1995; 173: 618-28
144. 144. Goodwin TM, Valenzuela GJ, Silver H, The Atosiban Study Group, et al. Dose ranging study of the oxytocin antagonist atosiban in the treatment of preterm labour. Obstet Gynecol 1996; 88: 331-6
145. 145. Goodwin TM, Millar L, North L, et al. The pharmacokinetics of the oxytocin antagonist atosiban in pregnant women with preterm uterine contractions. Am J Obstet Gynecol 1995; 173: 913-7
146. 146. Valenzuela GJ, Craig J, Berhardt MD, et al. Placental passage of the oxytocin antagonist atosiban. Am J Obstet Gynecol 1995; 172: 1304-6
147. 147. Andersen LF, Lyndrup J, Akerlund M, et al. Oxytocin receptor blockade: a new principle in the treatment of preterm labour. Am J Perinatol 1989; 6 (2): 196-9
148. 148. Akerlund M, Stromberg P, Hauksson A, et al. Inhibition of uterine contractions of premature labour with an oxytocin analogue. Br J Obstet Gynaecol 1987; 94: 1040-4
149. 149. Sibai BM, Romero R, Sanchez-Ramos L, et al. A double-blind placebo-controlled trial of an oxytocin-receptor antagonist (Antocin) in the treatment of preterm labour [abstract no. 2]. Am J Obstet Gynecol 1997; 176: S2
150. _ 150. Karim SM, Devlin J. Prostaglandin content of amniotic fluid during pregnancy and labour. J Obstet Gynaecol Br Commonw 1967; 74: 230-4
151. 151. Karim SM. Appearance of prostaglandin F2a in human blood during labour. BMJ 1968; 4: 618-21
152. 152. Karim SM, Hillier K. Prostaglandins and spontaneous abortion. J Obstet Gynaecol Br Commonw 1970; 77: 837-9
153. 153. Keirse MJ, Turnbull AC. E prostaglandins in amniotic fluid during late pregnancy and labour. J Obstet Gynaecol Br Commonw 1973; 80: 970-3
154. 154. Dubin NH, Johnson JWC, Calhoun S, et al. Plasma prostaglandin in pregnant women with term and preterm deliveries. Obstet Gynecol 1981; 57: 203-6
155. 155. Giannopoulos G, Jackson K, Kredentser J, et al. Prostaglandin E and F2 alpha receptors in human myometrium during the menstrual cycle and in pregnancy and labour. Am J Obstet Gynecol 1985; 153: 904-10
156. 156. Nakla S, Skinner K, Mitchell BF, et al. Changes in prostaglandin transfer across human fetal membranes obtained after spontaneous labour. Am J Obstet Gynecol 1986; 155: 1337-41
157. 157. Zuckerman H, Reiss U, Atad J, et al. The effect of indomethacin on plasma levels of prostaglandin F2 alpha in women in labour. Br J Obstet Gynaecol 1977; 84: 339-43
158. 158. Keirse MJ, Mitchell MD, Turnbull AC. Changes in prostaglandin F and 13,14-dihydro-15-keto-prostaglandin F concentrations in amniotic fluid at the onset of and during labour. Br J Obstet Gynaecol 1977; 84: 743-6
159. 159. Lackritz R, Tulchinsky D, Ryan KJ, et al. Plasma prostaglandin metabolites in human labour. Am J Obstet Gynecol 1978; 131: 484-9
160. 160. Keirse MJ, Flint AP, Turnbull AC. F prostaglandin in amniotic fluid during pregnancy and labour. J Obstet Gynaecol Br Commonw 1974; 81: 131-5
161. 161. Niebyl JR, Blake DA, White RD, et al. The inhibition of premature labour with indomethacin. Am J Obstet Gynecol 1980; 136: 1014-9
162. 162. Liggins GC. Initiation of spontaneous labour. Clin Obstet Gynecol 1983; 26: 47-55
163. 163. Wiqvist N, Lundstrom V, Green K. Premature labour and indomethacin. Prostaglandins 1975; 10: 515-26
164. 164. Halle H, Hengst P, Zusatztokolyse durch Prostaglandin-synthetasehemmung mit Indometacin. Z Gegburtshilfe Perinatol 1978; 182: 367-70
165. 165. Van Kets H, Thiery M, Derom R, et al. Perinatal hazards of chronic antenatal tocolysis with indomethacin. Prostaglandins 1979; 18: 893-907
166. 166. Suzanne F, Fresne JJ, Portal B, et al. Essai therapeutique de Iindométacine dans les menaces daccouchement prémature. Therapie 1980; 35: 751-70
167. 167. Keirse MJ. Potential hazards of prostaglandin synthetase inhibitors for management of pre-term labour. J Drug Res 1981; 6: 915-9
168. 168. Lewis RB, Schulman JD. Influence of acetylsalicylic acid, an inhibitor of prostaglandin synthesis, on the duration of human gestation and labour. Lancet 1973; 2: 1159-61
169. 169. Waltman R, Tricomi V, Palav A. Aspirin and indomethacin: effect of instillation/abortion time of midtrimester hypertonic saline induced abortion. Prostaglandins 1973; 3: 47-58
170. 170. Zuckerman H, Reiss U, Rubinstein I. Inhibition of human premature labour by indomethacin. Obstet Gynecol 1974; 44: 787-92
171. _ 171. Györy G, Kiss C, Benyo T, et al. Inhibition of labour by prostaglandin antagonist in impending abortion and preterm and term labour [letter]. Lancet 1974; 2: 293
172. 172. Schwartz A, Brook I, Insler V, et al. Effect of flufenamic acid on uterine contractions and plasma levels of 15-keto-13,14-dihydro-prostaglandin F2α in preterm labour. Gynecol Obstet Invest 1978; 9: 139-49
173. 173. Wiqvist N, Kjellmer I, Thiringer K, et al. Treatment of premature labour by prostaglandin synthetase inhibitors. Acta Biol Med Ger 1978; 37: 923-30
174. 174. Wilkinson Ar. Naproxen levels in preterm infants after maternal treatment. Lancet 1980; 2: 591-2
175. 175. Dornhöfer W, Mosler KH. Prostaglandine und β-Stimulatoren. In: Jung H, Klöck FK, editors. The 1165a (Partusisten) bei der Behandlung in der Geburtshilfe und Perinatologie. Stuttgart: Georg Thieme, 1975: 196-202
176. 176. Wolff F, Berg R, Bolte A. Klinische Untersuchungen zur wehenhemmenden Wirkung der Azetylsalizylsäure (ASS) und ihre Nebenwirkungen. Geburtshilfe Frauenheilkd 1981; 41: 96-100
177. 177. Grella P, Zanor P. Premature labour and indomethacin. Prostaglandins 1978; 16: 1007-17
178. 178. Zuckerman H, Shalev E, Gilad G, et al. Further study of the inhibition of premature labour by indomethacin. Part II. Double-blind study. J Perinat Med 1984; 12: 25-9
179. 179. Carlan SJ, OBrien WF, OLeary TD, et al. Randomized comparative trial of indomethacin and sulindac for the treatment of refractory preterm labour. Obstet Gynecol 1992; 79: 223-8
180. 180. Carlan SJ, OBrein WF, Jones MH, et al. Outpatient oral sulindac to prevent recurrence of preterm labour. Obstet Gynecol 1995; 85: 769-74
181. 181. Brogden RN, Heel RC, Speight TM, et al. Sulindac: a review of its pharmacological properties and therapeutic efficacy in rheumatic diseases. Drugs 1978; 16: 97-114
182. 182. Duggan DE, Hare LE, Ditzler BA, et al. The disposition of sulindac. Clin Pharmacol Ther 1976; 21: 326-35
183. 183. Higby K, Elliott B, King TS, et al. Human placental transfer of the prostaglandin inhibitor sulindac using an vitro model. J Soc Gynecol Invest 1995; 2: 526-30
184. 184. Kramer WB, Saade G, Ou C-N, et al. Placental transfer of sulindac and its active sulfide metabolite in humans. Am J Obstet Gynecol 1995; 172: 886-90
185. 185. Norton ME, Merrill J, Cooper BAB, et al. Neonatal complications after the administration of indomethacin for preterm labour. N Engl J Med 1993; 329: 1602-7
186. 186. Major CA, Lewis DF, Harding JA, et al. Tocolysis with indomethacin increases the incidence of necrotizing enterocolitis in the low birth weight neonate. Am J Obstet Gynecol 1994; 170: 102-6
187. 187. Van Overmeire B, Slootmackers V, De Loor J, et al. The addition of indomethacin to betamimetics for tocolysis: any benefit for the neonate? Eur J Obstet Gynecol Reprod Biol 1998; 77: 41-5
188. 188. Zuckerman H, Shalev E, Gilad G, et al. Further study of the inhibition of premature labour by indomethacin. Part I. J Perinat Med 1984; 12: 19-23
189. 189. Marpeau L, Bouillie J, Barrat J, et al. Obstetrical advantages and perinatal risks of indomethacin: a report of 818 cases. Fetal Diagn Ther 1994; 9: 110-5
190. 190. Gardner MO, Owen J, Skelly S, et al. Preterm delivery after indomethacin. J Reprod Med 1996; 41: 903-6
191. 191. Mamopoulos M, Assimakopoulos E, Reece EA, et al. Maternal indomethacin therapy in the treatment of polyhydramnios. Am J Obstet Gynecol 1990; 162: 1225-9
192. _ 192. Cabrol D, Landesman R, Muller J, et al. Treatment of polyhydramnios with prostaglandin synthetase inhibitor (indomethacin). Am J Obstet Gynecol 1987; 157: 422-6
193. 193. Macones GA, Robinson CA. Is there justification for using indomethacin in preterm labour? An analysis of neonatal risks and benefits. Am J Obstet Gynaecol 1997; 177: 819-24
194. 194. Mahony L, Carnero V, Brett C, et al. Prophylactic indomethacin in therapy for patent ductus arteriosus in very-low-birth-weight infants. N Engl J Med 1982; 306: 506-10
195. 195. McCarthy JS, Zies LG, Gelband H. Age-dependent closure of the patent ductus arteriosus by indomethacin. Pediatrics 1978; 62: 706-12
196. 196. Ivey HH, Kattwinkel J, Park TS, et al. Failure of indomethacin to close persistent ductus arteriosus in infants weighing less than 1000 grams. Br Heart J 1979; 41: 304-7
197. 197. Cooke RW, Pickering D. Poor response to oral indomethacin therapy for persistent ductus arteriosus in very low birth weight infants. Br Heart J 1979; 41: 301-3
198. 198. Eronen M, Pesonen E, Kurki T, et al. The effects of indomethacin and β-sympathomimetic agent on the fetal ductus arteriosus during treatment of premature labour: a randomized double-blind study. Am J Obstet Gynecol 1991; 164: 141-6
199. 199. Moise Jr KJ, Huhta JC, Shanf DS, et al. Indomethacin in the treatment of premature labour: effects on the fetal ductus arteriosus. N Engl J Med 1988; 319: 327-31
200. 200. Manchester D, Margolis HS, Sheldon RE. Possible association between maternal indomethacin therapy and primary pulmonary hypertension of the newborn. Am J Obstet Gynecol 1976; 126: 467-9
201. 201. Coceani F, Olley PM. The response of the ductus arteriosus to prostaglandins. Can J Physiol Pharmacol 1973; 51: 220-5
202. 202. Sharpe GL, Thaíme B, Larsson KS. Studies on closure of the ductus arteriosus. XI. Ductal closure in utero by a prostaglandin synthetase inhibitor. Prostaglandins 1974; 8: 363-8
203. 203. Besinger R, Niebyl J, Keys WG, et al. Randomized comparative trial of indomethacin and ritodrine for the long-term treatment of preterm labour. Am J Obstet Gynecol 1991; 164: 981-6
204. 204. Reynolds SRM. The effect of certain calcium salts on the rhythmically contracting and quiescent uterine fistula, with observations on the action of posterior pituitary extracts. Am J Physiol 1933; 105: 358-65
205. 205. Hall DG, McGuaghey HS, Corey EL, et al. The effects of magnesium sulfate therapy on the duration of labour. Am J Obstet Gynecol 1959; 78: 27-32
206. 206. Steer CM, Petrie RH. A comparison of magnesium sulfate and alcohol for the prevention of premature labour. Am J Obstet Gynecol 1977; 129: 1-4
207. 207. Cox SM, Sherman LM, Leveno KY. Randomized investigation of magnesium sulfate for prevention of preterm birth. Am J Obstet Gynecol 1990; 163: 767-72
208. 208. Ha L. Magnesium sulfate in prevention of preterm labour. Chung Hua I Hsueh Tsa Chih 1992 Mar; 72 (3): 158-61
209. 209. Sherer DM, Cialone PR, Abramowicz JS. Transient symptomatic subendocardial ischemia during intravenous magnesium sulfate tocolytic therapy. Am J Obstet Gynecol 1992; 166: 33-5
210. 210. Lamm CJ, Norton KJ, Murphy RJ, et al. Congenital rickets associated with magnesium sulfate infusion for tocolysis. J Pediatr 1988; 113: 1078-82
211. 211. Holocomb Jr WL, Shackelford GD, Petrie RH. Magnesium tocolysis and neonatal bone abnormalities: a controlled study. Obstet Gynecol 1991; 78: 611-4
212. _ 212. Mittendorf R, Covert R, Boman J, et al. Is tocolytic magnesium sulphate associated with increased total paediaetric mortality? Lancet 1997; 350 (9090): 1517-8
213. 213. Mittendorf R, Pryde P, Khoshnood B, et al. If tocolytic magnesium sulfate is associated with excess total pediatric mortality, what is its impact? Obstet Gynecol 1998; 92: 308-11
214. 214. Emig RO, Napier JV, Brazie JV. Inflammation of the placenta. Correlation with prematurity and perinatal death. Obstet Gynecol 1961; 17: 743-50
215. 215. Romero R, Mazor M. Infection and preterm labour. Clin Obstet Gynecol 1988; 31: 553-84
216. 216. Minkoff H. Prematurity: infection as an etiologic factor. Obstet Gynecol 1983; 62: 137-44
217. 217. Salafia CM, Vogel CA, Vintzileos AM, et al. Placental pathologic findings in preterm birth. Am J Obstet Gynecol 1991; 165: 934-8
218. 218. Armer TL, Duff P. Intra-amniotic infection in patients with intact membranes and preterm labour. Obstet Gynecol Surv 1991; 46: 589-93
219. 219. Meis PJ, Goldenberg RL, Mercer B, et al. The preterm prediction study: significance of vaginal infections. National Institute of Child Health and Human Development maternal-fetal medicine units network. Am J Obstet Gynecol 1995; 173 (4): 1231-5
220. 220. McGregor JA, French JI, Reller LB, et al. Adjunctive erythromycin treatment for idiopathic preterm labour: results of a randomized, double-blinded placebo-controlled trial. Am J Obstet Gynecol 1986; 154: 98-103
221. 221. Winkler M, Baumann L, Ruckhäberle K-E, et al. Erythromycin therapy for subclinical intrauterine infections in threatened preterm delivery: a preliminary report. J Perinat Med 1988; 16: 253-6
222. 222. Morales WJ, Angel JL, OBrien WF, et al. A randomized study of antibiotic therapy in idiopathic preterm labour. Obstet Gynecol 1988; 72: 829-33
223. 223. Newton ER, Dinsmoor MJ, Gibbs RS. A randomized, blinded, placebo-controlled trial of antibiotics in idiopathic preterm labour. Obstet Gynecol 1989; 74: 562-6
224. 224. Newton ER, Shields L, Ridgeway III LE, et al. Combination antibiotics and indomethacin in idiopathic preterm labour: a randomized double-blind clinical trial. Am J Obstet Gynecol 1991; 165: 1753-9
225. 225. McGregor JA, French JI, Seo K. Adjunctive clindamycin therapy for preterm labour: results of a double-blind, placebo-controlled trial. Am J Obstet Gynecol 1991; 165: 867-75
226. 226. McCaul JF, Perry KG, Moore JL, et al. Adjunctive antibiotic treatment of women with preterm rupture of membranes or preterm labour. Int J Gynecol Obstet 1992; 38: 19-24
227. 227. Romero R, Sibai B, Caritis S, et al. Antibiotic treatment of preterm labour with intact membranes: a multicenter, randomized, double-blinded, placebo-controlled trial. Am J Obstet Gynecol 1993; 169: 764-74
228. 228. Norman K, Paltinson RC, de Souza J, et al. Ampicillin and metronidazole treatment in preterm labour: a multicentre, randomised controlled trial. Br J Obstet Gynaecol 1994; 101: 404-8
229. 229. Gordon MC, Samuels P, Shubert P, et al. A randomized, prospective study of adjunctive ceftizoxime in preterm labour. Am J Obstet Gynecol 1995; 172: 1546-52
230. 230. Egarter C, Leitich H, Husslein P, et al. Adjunctive antibiotic treatment in preterm labour and neonatal morbidity: a meta-analysis. Obstet Gynecol 1996; 88: 303-9
231. _ 231. Schiff E, Sivan E, Terry S, et al. Currently recommended oral regimens for ritodrine tocolysis result in extremely low plasma levels. Am J Obstet Gynecol 1993; 169 (4): 1059-64
232. 232. Macones GA, Berlin M, Berlin JA. Efficacy of oral beta-agonist maintenance therapy in preterm labour: a meta-analysis. Obstet Gynecol 1995; 85 (2): 313-8
233. 233. Foley MR, Landon MB, Gabbe SG, et al. Effect of prolonged oral terbutaline therapy on glucose tolerance in pregnancy. Am J Obstet Gynecol 1993; 168: 100-5
234. 234. Holleboom CAG, Merkus JMWM, van Elferen LWM, et al. Double-blind evaluation of ritodrine sustained release for oral maintenance of tocolysis after active preterm labour. Br J Obstet Gynaecol 1996; 103: 702-5
235. 235. Lewis R, Mercer BM, Salama M, et al. Oral terbutaline after pareneeral tocolysis: a randomized double-blind, placebo-controlled trial. Am J Obstet Gynecol 1996; 175: 834-7
236. 236. Rust OA, Bofill JA, Arriola RM, et al. The clinical efficacy of oral tocolytic therapy. Am J Obstet Gynecol 1996; 175: 838-42
237. 237. How HY, Hughes SA, Vogel RL, et al. Oral terbutaline in the outpatient management of preterm labour. Am J Obstet Gynecol 1995; 175: 1518-22
238. _ 238. Ridgeway LB, Muise R, Wright IW, et al. A prospective randomized comparison of oral terbutaline and magnesium oxide for maintenance of tocolysis. Am J Obstet Gynecol 1990; 163 (3): 879-82
239. 239. Sanchez-Ramos L, Wears RL, Caudier FL, et al. The efficacy of maintenance therapy after acute tocolysis: a meta-analysis (abstract no. 41). Am J Obstet Gynecol 1998; 178: 178, S19
240. 240 Leveno KJ, Little BB, Cunningham FG. The national impact of ritodrine hydrochloride for inhibition of preterm labour. Obstet Gynecol 1991; 76: 12-15
241. 241. Tejani NA, Verma UL. Effect of tocolysis on incidence of low birth weight. Obstet Gynecol 1983; 61: 556-8
242. 242. King JF, Grant A, Keirse MJNC, et al. Beta-mimetics in preterm labour: an overview of the randomized controlled trials. Br J Obstet Gynaecol 1988; 95: 211-22